Delivery Order SPE2DB20D2104-SPE2DB25FMRJB
- Not listed
- The Defense Logistics Agency awarded a $21,011.11 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The order will be fulfilled from the company's facility in...
- The Defense Logistics Agency awarded a $49,585.69 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml). The contract represents a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors with a ceiling value of $4,897.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a $1,904.63 delivery order contract to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors with a completion date of August 19, 2025. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing as the pricing mechanism. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $13,172.65 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors with a ceiling value of $1,088.36. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract utilizes firm fixed-price terms with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a contract value of $4,568.72. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $64,455.47 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,632.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL units). The contract was competitively awarded with no set-aside designation and maintains an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMRJBDelivery Order
The Defense Logistics Agency awarded a $1,632.54 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors. This is a firm fixed-price contract with an ultimate completion date of May 21, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's comprehensive $999,999,999.00 IDC (designated SPE2DX) with the Defense Logistics Agency, which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support defense and veteran healthcare systems. Mounjaro, a diabetes medication, represents one of the specialized pharmaceutical products the company regularly provides through its federal medical supply contracts with the DLA and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 5/20/25 |